Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers.
<h4>Background</h4>Pulmonary exacerbations in alpha-1 antitrypsin deficiency (AATD) related lung disease are a significant contributor to disease burden, as with usual COPD. Separating the early stages of an exacerbation from the day-to-day variation in stable COPD is central to the conc...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297125&type=printable |
| _version_ | 1827356669562060800 |
|---|---|
| author | Paul Ellis Gita Parekh Annelyse Duvoix Lynne Watson Alex Sharp Farah Mobeen Anita Pye Robert Stockley Alice Turner |
| author_facet | Paul Ellis Gita Parekh Annelyse Duvoix Lynne Watson Alex Sharp Farah Mobeen Anita Pye Robert Stockley Alice Turner |
| author_sort | Paul Ellis |
| collection | DOAJ |
| description | <h4>Background</h4>Pulmonary exacerbations in alpha-1 antitrypsin deficiency (AATD) related lung disease are a significant contributor to disease burden, as with usual COPD. Separating the early stages of an exacerbation from the day-to-day variation in stable COPD is central to the concerns of both clinicians and patients and has been identified as a research priority by NIHR. Clinical tools that distinguish baseline symptoms from those of an exacerbation could allow early and appropriate treatment of AECOPD to reduce the impact and potentially may slow disease progression thereby improving survival and quality of life. Candidate tools include symptom diaries and biomarkers of infection and acute inflammation. Urinary biomarkers of AECOPD have yet to be explored in AATD related COPD.<h4>Methods</h4>55 patients with AATD related lung disease with a history of 2 or more AECOPD in the preceding year were prospectively followed for 18 months. Each patient recorded symptom scores daily via an electronic symptom diary (eDiary) based on Bronkotest. Urinary biomarkers for AAT, NE, CRP, TIMP1 and desmosine were measured weekly using a home urinary lateral flow device. During self-reported AECOPD patients were asked to perform urine analysis on the first 7 consecutive days.<h4>Results</h4>Type I Anthonisen exacerbations and episodes occurring in autumn/winter lasted longer than Type II/III exacerbations and spring/summer episodes respectively. Median urinary CRP concentration across all study participants increased during Type I AECOPD. eDiary adherence was 68% over a median of 17.8 months (IQR 15.7 to 18.5).<h4>Conclusions</h4>Use of an eDiary and urinary biomarkers to detect and characterise AECOPD remotely in AATD related lung disease is feasible over a prolonged period and paves the way for precision detection of exacerbations. |
| first_indexed | 2024-03-08T05:13:17Z |
| format | Article |
| id | doaj.art-8ce134067ea44070a1a6da2cccd69f95 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-03-08T05:13:17Z |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-8ce134067ea44070a1a6da2cccd69f952024-02-07T05:31:04ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01192e029712510.1371/journal.pone.0297125Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers.Paul EllisGita ParekhAnnelyse DuvoixLynne WatsonAlex SharpFarah MobeenAnita PyeRobert StockleyAlice Turner<h4>Background</h4>Pulmonary exacerbations in alpha-1 antitrypsin deficiency (AATD) related lung disease are a significant contributor to disease burden, as with usual COPD. Separating the early stages of an exacerbation from the day-to-day variation in stable COPD is central to the concerns of both clinicians and patients and has been identified as a research priority by NIHR. Clinical tools that distinguish baseline symptoms from those of an exacerbation could allow early and appropriate treatment of AECOPD to reduce the impact and potentially may slow disease progression thereby improving survival and quality of life. Candidate tools include symptom diaries and biomarkers of infection and acute inflammation. Urinary biomarkers of AECOPD have yet to be explored in AATD related COPD.<h4>Methods</h4>55 patients with AATD related lung disease with a history of 2 or more AECOPD in the preceding year were prospectively followed for 18 months. Each patient recorded symptom scores daily via an electronic symptom diary (eDiary) based on Bronkotest. Urinary biomarkers for AAT, NE, CRP, TIMP1 and desmosine were measured weekly using a home urinary lateral flow device. During self-reported AECOPD patients were asked to perform urine analysis on the first 7 consecutive days.<h4>Results</h4>Type I Anthonisen exacerbations and episodes occurring in autumn/winter lasted longer than Type II/III exacerbations and spring/summer episodes respectively. Median urinary CRP concentration across all study participants increased during Type I AECOPD. eDiary adherence was 68% over a median of 17.8 months (IQR 15.7 to 18.5).<h4>Conclusions</h4>Use of an eDiary and urinary biomarkers to detect and characterise AECOPD remotely in AATD related lung disease is feasible over a prolonged period and paves the way for precision detection of exacerbations.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297125&type=printable |
| spellingShingle | Paul Ellis Gita Parekh Annelyse Duvoix Lynne Watson Alex Sharp Farah Mobeen Anita Pye Robert Stockley Alice Turner Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. PLoS ONE |
| title | Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. |
| title_full | Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. |
| title_fullStr | Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. |
| title_full_unstemmed | Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. |
| title_short | Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers. |
| title_sort | characteristics of alpha 1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297125&type=printable |
| work_keys_str_mv | AT paulellis characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT gitaparekh characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT annelyseduvoix characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT lynnewatson characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT alexsharp characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT farahmobeen characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT anitapye characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT robertstockley characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers AT aliceturner characteristicsofalpha1antitrypsindeficiencyrelatedlungdiseaseexacerbationsusingadailysymptomdiaryandurinarybiomarkers |